Cargando…
Radiosensitivity of colorectal cancer to (90)Y and the radiobiological implications for radioembolisation therapy
Approximately 50% of all colorectal cancer (CRC) patients will develop metastasis to the liver. (90)Y selective internal radiation therapy (SIRT) is an established treatment for metastatic CRC. There is still a fundamental lack of understanding regarding the radiobiology underlying the dose response...
Autores principales: | Lee, Boon Q, Abbott, Elliot M, Able, Sarah, Thompson, James M, Hill, Mark A, Kartsonaki, Christiana, Vallis, Katherine A, Falzone, Nadia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOP Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611228/ https://www.ncbi.nlm.nih.gov/pubmed/31117062 http://dx.doi.org/10.1088/1361-6560/ab23c4 |
Ejemplares similares
-
Trans-arterial hepatic radioembolisation of yttrium-90 microspheres
por: Murthy, R, et al.
Publicado: (2006) -
Stereotactic Inverse Dose Planning After Yttrium-90 Selective Internal Radiation Therapy in Hepatocellular Cancer
por: Abbott, Elliot, et al.
Publicado: (2020) -
Targeting Micrometastases: The Effect of Heterogeneous Radionuclide Distribution on Tumor Control Probability
por: Falzone, Nadia, et al.
Publicado: (2019) -
Improved outcome of (131)I-mIBG treatment through combination with external beam radiotherapy in the SK-N-SH mouse model of neuroblastoma
por: Corroyer-Dulmont, Aurélien, et al.
Publicado: (2017) -
Targeted Radionuclide Therapy: New Advances for Improvement of Patient Management and Response
por: Malcolm, Javian, et al.
Publicado: (2019)